Suppr超能文献

肝活检的适应证。

The indications for liver biopsy.

机构信息

Institute of Pathology, Ruhr-University Bochum, Germany.

出版信息

Dtsch Arztebl Int. 2012 Jul;109(27-28):477-83. doi: 10.3238/arztebl.2012.0477. Epub 2012 Jul 9.

Abstract

BACKGROUND

Despite improvements in serological and radiological techniques, liver biopsy remains the most reliable way to diagnose diffuse hepatic disease and hepatic nodules. The indications for this invasive technique must be weighed against the small, but not negligible, risk of a complication.

METHODS

The indications for liver biopsy are summarized on the basis of a selective review of the literature, including the published recommendations and position statements of specialty societies in Germany and abroad. The conclusions are supplemented with an evaluation of the authors' own experience.

RESULTS

The success of liver biopsy depends not only on the selection of the puncture method and on due attention to the relative and absolute contraindications, but also on the experience of the person carrying out the procedure. For patients with hepatitis of various etiologies, liver biopsy is used not only to establish the cause of the disorder, but also to assess the degree of inflammatory activity (grading) and the extent of fibrosis (staging).

CONCLUSION

Liver biopsy enables the reliable diagnosis of hepatic lesions and is an important aid to treatment planning and prognostication.

摘要

背景

尽管血清学和影像学技术有所提高,但肝活检仍然是诊断弥漫性肝疾病和肝结节的最可靠方法。这种有创技术的适应证必须与较小但并非可以忽略不计的并发症风险相权衡。

方法

根据对文献的选择性回顾,总结了肝活检的适应证,包括德国和国外专业协会的已发表建议和立场声明。结论部分还结合了作者自身经验的评估。

结果

肝活检的成功不仅取决于穿刺方法的选择以及对相对和绝对禁忌证的关注,还取决于进行该操作的人员的经验。对于各种病因的肝炎患者,肝活检不仅用于确定疾病的原因,还用于评估炎症活动度(分级)和纤维化程度(分期)。

结论

肝活检能够可靠地诊断肝病变,是治疗计划和预后的重要辅助手段。

相似文献

1
The indications for liver biopsy.
Dtsch Arztebl Int. 2012 Jul;109(27-28):477-83. doi: 10.3238/arztebl.2012.0477. Epub 2012 Jul 9.
2
[Analysis of liver biopsy experience in a regional hospital].
Rev Invest Clin. 2002 Mar-Apr;54(2):139-44.
3
[Transjugular liver puncture].
Bildgebung. 1993 Sep;60(3):161-8.
5
[Liver biopsy: Which role in patient management?].
Ann Pathol. 2010 Dec;30(6):464-9. doi: 10.1016/j.annpat.2010.08.026. Epub 2010 Nov 26.
6
Liver biopsy for histological assessment: The case in favor.
Saudi J Gastroenterol. 2010 Apr-Jun;16(2):133-9. doi: 10.4103/1319-3767.61245.
7
[Current trends in liver biopsy indications in chronic liver diseases].
Presse Med. 2012 Nov;41(11):1064-70. doi: 10.1016/j.lpm.2012.01.034. Epub 2012 Mar 15.
9
Liver needle biopsy in Iraninan pediatric patients: diagnostic significance and pattern of liver diseases.
Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):10-3. doi: 10.4103/0377-4929.44953.

引用本文的文献

1
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.
Liver Cancer. 2023 Apr 24;13(1):6-28. doi: 10.1159/000530700. eCollection 2024 Feb.
2
Application of ultrasound elastography for monitoring the effects of TβR1 shRNA therapy on hepatic fibrosis in a rat model.
PLoS One. 2021 Jun 28;16(6):e0253150. doi: 10.1371/journal.pone.0253150. eCollection 2021.
4
Evolution of the liver biopsy and its future.
Transl Gastroenterol Hepatol. 2021 Apr 5;6:20. doi: 10.21037/tgh.2020.04.01. eCollection 2021.
5
Non-Invasive Reliable Methods to Objectify the Positive Influence of Hepatitis C Virus Treatment on Liver Stiffness.
Gastroenterology Res. 2021 Feb;14(1):31-40. doi: 10.14740/gr1347. Epub 2021 Feb 19.
7
Endoscopic ultrasound guided liver biopsy: Recent evidence.
World J Gastrointest Endosc. 2020 Mar 16;12(3):83-97. doi: 10.4253/wjge.v12.i3.83.
9
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
World J Hepatol. 2019 Jan 27;11(1):1-18. doi: 10.4254/wjh.v11.i1.1.
10
Nanoparticles for the treatment of liver fibrosis.
Int J Nanomedicine. 2017 Sep 20;12:6997-7006. doi: 10.2147/IJN.S145951. eCollection 2017.

本文引用的文献

1
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline].
Z Gastroenterol. 2011 Jul;49(7):871-930. doi: 10.1055/s-0031-1273462. Epub 2011 Jul 11.
3
Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.
Virchows Arch. 2011 May;458(5):511-23. doi: 10.1007/s00428-011-1066-1. Epub 2011 Mar 26.
4
Management of hepatocellular carcinoma: an update.
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
5
Autoimmune hepatitis.
J Hepatol. 2011 Jul;55(1):171-82. doi: 10.1016/j.jhep.2010.12.012. Epub 2010 Dec 15.
6
Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopy.
J Hepatol. 2011 Mar;54(3):584-5. doi: 10.1016/j.jhep.2010.09.033. Epub 2010 Oct 23.
7
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.
J Hepatol. 2011 Feb;54(2):374-85. doi: 10.1016/j.jhep.2010.09.002. Epub 2010 Sep 18.
9
Bleeding complication with liver biopsy: is it predictable?
Clin Gastroenterol Hepatol. 2010 Oct;8(10):826-9. doi: 10.1016/j.cgh.2010.06.010. Epub 2010 Jun 25.
10
Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
Gastroenterology. 2010 Aug;139(2):393-408, 408.e1-2. doi: 10.1053/j.gastro.2010.06.013. Epub 2010 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验